ImmuneRegen(R) Appoints Renowned Hematologist Ivan N. Rich, Ph.D. to Advisory Board
genengnews.com May 6, 2008 1 related
News source: Business Wire ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. , today announced it has appointed Ivan N. Rich, Ph.D., to its advisory board. Dr. Rich's experience as the founder, chairman and C.E.O. of HemoGenix(R)...













